Cellectis CLLS
NASDAQ CLLS
$3.24 -0.08 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Cellectis (CLLS) Beginning Cash Balance (2021 - 2022)

Cellectis (CLLS) posted quarterly Beginning Cash Balance of $61.5 million for Q1 2026, down 57.05% year-over-year from $143.3 million in Q1 2025, and down 57.05% quarter-over-quarter from $143.3 million in Q1 2025.

Analysis

Cellectis (CLLS) Beginning Cash Balance (2021 - 2022) Analysis & Trends

Cellectis' Beginning Cash Balance history runs 12 years deep, the most recent figure standing at $61.5 million for Q1 2026.

  • In Q1 2026, Beginning Cash Balance fell 57.05% year-over-year to $61.5 million; the TTM figure through Mar 2026 stood at $204.8 million (down 26.85% YoY), while the FY2016 annual figure was $347.9 million, up 178.76% from the prior year.
  • Beginning Cash Balance for Q1 2026 stood at $61.5 million, down from $143.3 million in the prior quarter.
  • The five-year high for Beginning Cash Balance was $185.6 million in Q1 2022, with the low at $61.5 million in Q1 2026.
  • The 5-year median for Beginning Cash Balance is $136.7 million (2024), against an average of $124.1 million.
  • The sharpest annual moves came in 2024 and 2026: Beginning Cash Balance jumped 46.66% in 2024, then tumbled 57.05% in 2026.
  • Cellectis' Beginning Cash Balance stood at $185.6 million in 2022, then plunged by 49.79% to $93.2 million in 2023, then surged by 46.66% to $136.7 million in 2024, then rose by 4.79% to $143.3 million in 2025, then sank by 57.05% to $61.5 million in 2026.
  • Business Quant data shows CLLS's Beginning Cash Balance at $61.5 million in Q1 2026, $143.3 million in Q1 2025, and $136.7 million in Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Cellectis 321.90 Mn 155.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 14.42 Mn
Mar 31, 2021 18.29 Mn